Immunologic response to high-dose influenza vaccination in patients with primary central nervous system malignancy (PCNSM) [abstract]. Strowd RE, Russell G, Harmon M, Carter AF, Chan MD, Tatter SB, Laxton AW, High K, Lesser G.. J Clin Oncol. 2015;33(15 Suppl):e20669.
A pilot study of influenza vaccine immunogenicity in patients with malignant central nervous system (CNS) tumors [abstract]. Strowd RE, Swett K, Harmon M, Pop-Vicas A, Chan M, Tatter SB, Ellis TL [deceased], Blevins M, High K, Lesser GJ.. Neuro Oncol. 2012;14(Suppl 6):154.
The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies. Strowd RE III, Knovich MA, Lesser GJ.. Curr Treat Options Oncol. 2012;13(4):451-464.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.
Roy E. Strowd, M.D.
Assistant Professor, Neurology